Literature DB >> 1489134

A multicenter registry of patients with acute respiratory distress syndrome. Physiology and outcome.

P J Sloane1, M H Gee, J E Gottlieb, K H Albertine, S P Peters, J R Burns, G Machiedo, J E Fish.   

Abstract

In a multicenter registry conducted over 2 yr of patients with acute respiratory distress syndrome (ARDS), we enrolled 153 patients and collected data daily for 7 consecutive days and weekly thereafter until death or hospital discharge. The purposes of the registry were (1) to determine whether a more liberal definition of ARDS (PaO2/FIO2 < or = 250; bilateral pulmonary infiltrates within 7 days) than those commonly used would result in enrollment of patients earlier in their clinical course, and (2) to study the clinical course of the syndrome in survivors and nonsurvivors. The mortality rate was 54% and it was significantly greater in older versus younger patients (75% versus 37%) and in septic versus nonseptic patients (60% versus 43%). We found that the definition of ARDS used for the registry resulted in enrollment of patients 1 to 7 days earlier than was the case when other published definitions of ARDS were applied to the patient population. Fewer than 2% of the patients failed to meet one of the nonregistry definitions of ARDS within 7 days. The mortality rate was independent of the definition used to identify ARDS patients. Our results suggest that a more liberal definition of ARDS than those commonly used can result in identification of the same population of patients earlier in their clinical course.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1489134     DOI: 10.1164/ajrccm/146.2.419

Source DB:  PubMed          Journal:  Am Rev Respir Dis        ISSN: 0003-0805


  47 in total

Review 1.  Acute respiratory distress syndrome and nosocomial pneumonia.

Authors:  T T Bauer; A Torres
Journal:  Thorax       Date:  1999-11       Impact factor: 9.139

Review 2.  The pulmonary physician in critical care. 5: Acute lung injury and the acute respiratory distress syndrome: definitions and epidemiology.

Authors:  K Atabai; M A Matthay
Journal:  Thorax       Date:  2002-05       Impact factor: 9.139

3.  Clinical Characteristics and Outcomes Are Similar in ARDS Diagnosed by Oxygen Saturation/Fio2 Ratio Compared With Pao2/Fio2 Ratio.

Authors:  Wei Chen; David R Janz; Ciara M Shaver; Gordon R Bernard; Julie A Bastarache; Lorraine B Ware
Journal:  Chest       Date:  2015-12       Impact factor: 9.410

4.  Predictors of mortality in mechanically ventilated patients.

Authors:  T D Sudarsanam; L Jeyaseelan; K Thomas; G John
Journal:  Postgrad Med J       Date:  2005-12       Impact factor: 2.401

5.  Involvement of the Bufadienolides in the Detection and Therapy of the Acute Respiratory Distress Syndrome.

Authors:  Mir M K Abbas; B Patel; Q Chen; W Jiang; B Moorthy; R Barrios; J B Puschett
Journal:  Lung       Date:  2017-03-04       Impact factor: 2.584

Review 6.  Acute respiratory distress syndrome: pharmacological treatment options in development.

Authors:  R D Hite; P E Morris
Journal:  Drugs       Date:  2001       Impact factor: 9.546

7.  The monitoring of acute cor pulmonale is still necessary in "Berlin" ARDS patients.

Authors:  D Chiumello; A Pesenti
Journal:  Intensive Care Med       Date:  2013-08-14       Impact factor: 17.440

Review 8.  Endothelial modification of pulmonary vascular tone.

Authors:  N P Curzen; K B Jourdan; J A Mitchell
Journal:  Intensive Care Med       Date:  1996-06       Impact factor: 17.440

9.  The acute respiratory distress syndrome: definitions, severity and clinical outcome. An analysis of 101 clinical investigations.

Authors:  P Krafft; P Fridrich; T Pernerstorfer; R D Fitzgerald; D Koc; B Schneider; A F Hammerle; H Steltzer
Journal:  Intensive Care Med       Date:  1996-06       Impact factor: 17.440

10.  Effects of propofol on endotoxin-induced acute lung injury in rabbit.

Authors:  Sang Hyun Kwak; Jeong Il Choi; Jong Tae Park
Journal:  J Korean Med Sci       Date:  2004-02       Impact factor: 2.153

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.